Kures, inc.
I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression. Kures, Inc. Team: Andrew Kruegel
Read MoreBioZAP
Our technology is a 3D microfluidic tumor array platform which will be used for personalized medicine by evaluating the therapeutic response of biopsy samples. Zeynep Dereli-Korkut
Read MoreARL Designs
ARL Designs — Superhydrophobic Virtual-Well Microplates Enabling Accurate Nanoliter Dispensing for High Throughput/Content Screening at Low Cost. ARL Designs Team: Amy Lyons Xiaoxiao Chen Beth Kujan
Read MoreAddicaid
Addicaid is an empowering social recovery platform and resource for recovering addicts and alcoholics that controls addiction to build healthy, sustainable recoveries. Addicaid Team: Ryan Wilhelm Sam Frons
Read MoreInfrasonic Monitoring
InfraSonic Monitoring (ISM) is developing a wearable noninvasive cardiac monitoring device to provide users critical information in nonclinical settings. Infrasonic Monitoring Team: Ohad BarSimanTov, PhD
Read MoreScalable Genomics
Scalable Genomics provides bioinformatics software for plug-in-play analysis of Big Data from genomic sequencing of clinical, environmental, genomic, and forensic samples. Scalable Genomics Team: Ntrino Krampis
Read MorePHD Biosciences
We are developing an enzyme inhibitor with pico-‐molar binding affinity and minimal toxicity as a once daily, oral therapeutic for the treatment of triple-‐negative breast cancer. Nanomedics LLC Team: Michael…
Read MoreOptologix
Optologix — Our product uses light to activate gene expression in cells and animals, allowing for nontoxic, rapid, precisely timed and localized induction unmatched by chemical-based methods. Optologix Team: Kevin…
Read MoreNY Protein Biologics
NY Protein Biologics will harness unique know-how and patent-pending processes to deliver products and develop new technologies that are central to the biotechnology and pharmaceutical industries. NY Protein Biologics Team:…
Read MoreNomoCan Pharmaceuticals
Utilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer. NomoCan Pharmaceuticals Team: Ehsan Sarafraz-Yazdi,…
Read More